RNPC3 and systemic lupus erythematosus: Some authors described that anti-RNP antibodies may be present in defined rheumatic diseases (RD), and associated with particular clinical features, for example, like scleroderma-like features in patients (pts) with systemic lupus erythematosus (SLE).